- Updated Pneumococcical Vaccine Guidelines
- National Lung Screening Trial Halted
- Diagnostic and Statistical Manual of Mental Disorders (DSM-5) introduces first draft
- Oil Spill In the Gulf
- First Synthetic Cell
- New Superbug :NDM-1
- Genetic Link to ADHD
Updated Pneumococcical Vaccine Guidelines
The Centers for Disease Control and Prevention in September updated guidelines for use of the 23-valent pneumococcal polysaccharide vaccine in adults. Changes include the recommendation that all persons aged 19 to 64 years with chronic or immunosuppressive medical conditions, including asthma, should receive the vaccine.